Synthesis history

Two substantive OpenAI publications from June 17 are the main additions. LifeSciBench provides the first expert-validated benchmark designed specifically for life-science AI, placing GPT-Rosalind at 36.1% versus GPT-5.5…

The main new development is the identification of a GitHub repository (maris205/open-rosalind) explicitly described as 'open source version of gpt rosalind,' which partially resolves the previously open question about t…

The substantive new development this pass is a biorxiv preprint titled 'Open-Rosalind: Tool-First Biomedical LLM Agents with Process...' submitted May 2026, which partially answers the previously open question about an …

New items this pass are entirely social amplification — English and Spanish-language tweets sharing existing coverage of the June 3-4 updates, with no new claims, institutional voices, or events. The thread's background…

New items this pass are primarily social amplification of the June 3-4 updates, now extended to trade press (FierceBiotech, CNET) and multilingual markets through June 7. A biowarfare-focused Twitter account engaged wit…

New items this pass are primarily social amplification of the June 3-4 updates across multilingual markets, with no new substantive voices or policy developments. One unverified tweet referenced 'open-rosalind, open sou…

OpenAI launched GPT-Rosalind in April 2026 as a domain-specialized frontier reasoning model for biology, drug discovery, and translational medicine, with access restricted from the start to a trusted-access program for …